• Thumbnail for Bristol Myers Squibb
    The Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb (BMS), is an American multinational pharmaceutical company. Headquartered in Princeton...
    96 KB (7,620 words) - 18:57, 12 September 2024
  • Thumbnail for The Bristol-Myers Squibb Children's Hospital
    The Bristol-Myers Squibb Children's Hospital at Robert Wood Johnson University Hospital (BMSCH) is a freestanding, 68-bed pediatric acute care children's...
    37 KB (2,630 words) - 18:49, 26 August 2024
  • Between 1977 and 2006, the Bristol-Myers Squibb Foundation presented annual awards of US$50,000 to scientists for distinguished achievements in fields...
    9 KB (124 words) - 00:50, 5 February 2024
  • Thumbnail for John Ripley Myers
    as Bristol-Myers Squibb. Bristol-Myers Squibb is one of the largest pharmaceutical companies in the world. Myers' stepmother, Mary Ware Hewitt Myers (1848–1942)...
    7 KB (721 words) - 03:50, 21 June 2023
  • "Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2023" (PDF). "Bristol Myers Squibb Q4 2022 Results" (PDF). "Bristol Myers...
    62 KB (2,735 words) - 16:33, 29 August 2024
  • William McLaren Bristol (28 July 1860 – 1935) was one of the two co-founders of Bristol-Myers, now part of Bristol-Myers Squibb. Myers and Bristol founded the...
    2 KB (158 words) - 06:30, 24 May 2022
  • Bristol-Myers Squibb Co. v. Superior Court of California, San Francisco County, 582 U.S. ___ (2017), was a United States Supreme Court case in which the...
    10 KB (1,108 words) - 19:26, 7 September 2024
  • growth was delayed by approximately 4.1 months. In September 2001, Bristol-Myers Squibb committed $2 billion (including a $1 billion up-front cash payment)...
    20 KB (2,186 words) - 18:24, 3 August 2024
  • treatment. In June 2022, Owkin entered a strategic alliance with Bristol-Myers Squibb to help them design potentially more precise and efficient clinical...
    21 KB (1,806 words) - 09:58, 6 September 2024
  • Thumbnail for Excedrin (brand)
    contains paracetamol, aspirin and caffeine. It was manufactured by Bristol-Myers Squibb until it was purchased by Novartis in July 2005 along with other...
    14 KB (1,368 words) - 00:17, 10 September 2024
  • Thumbnail for Deucravacitinib
    Deucravacitinib (category Drugs developed by Bristol Myers Squibb)
    2 (TYK2) inhibitor and it is taken by mouth. It was developed by Bristol Myers Squibb. Deucravacitinib was approved for medical use in the United States...
    12 KB (697 words) - 09:25, 1 July 2024
  • Thumbnail for Apixaban
    Apixaban (category Drugs developed by Bristol Myers Squibb)
    medications. It is a direct factor Xa inhibitor. In 2007, Pfizer and Bristol-Myers Squibb began development of apixaban as an anticoagulant. Apixaban was approved...
    25 KB (2,069 words) - 01:49, 1 September 2024
  • equity investment agreement with Bristol-Myers Squibb. Under the terms of the agreement, Bristol Bristol-Myers Squibb will supply Opdivo®, its PD-1 inhibitor...
    18 KB (1,956 words) - 13:48, 9 May 2024
  • Thumbnail for Robert Wood Johnson University Hospital
    transplantation, cancer care, and women's and children's care including The Bristol-Myers Squibb Children's Hospital at RWJUH, which has several areas of pediatric...
    37 KB (3,205 words) - 07:59, 21 February 2023
  • Thumbnail for Cefepime
    found no mortality difference. Cefepime was patented in 1982 by Bristol-Myers Squibb and approved for medical use in 1994. It is available as a generic...
    8 KB (600 words) - 08:50, 7 September 2024
  • Thumbnail for E. R. Squibb
    pharmaceutics who founded E. R. Squibb and Sons, which eventually became part of the modern pharmaceutical giant Bristol-Myers Squibb. Squibb was born in Wilmington...
    11 KB (1,134 words) - 00:08, 7 September 2024
  • Thumbnail for Thalidomide
    Thalidomide (category Drugs developed by Bristol Myers Squibb)
    Thalidomide, sold under the brand names Contergan and Thalomid among others, is an oral medication used to treat a number of cancers (e.g., multiple myeloma)...
    76 KB (7,430 words) - 00:03, 15 September 2024
  • Thumbnail for John C. Martin (businessman)
    from 1978 to 1984. Martin was director of antiviral chemistry at Bristol-Myers Squibb from 1984 to 1990. Martin joined the American biotechnology company...
    15 KB (1,443 words) - 22:51, 20 May 2024
  • Thumbnail for Celgene
    Celgene (category Bristol Myers Squibb)
    Delaware, headquartered in Summit, New Jersey, and a subsidiary of Bristol Myers Squibb (BMS). Celgene was originally a unit of Celanese. In 1986, Celanese...
    32 KB (2,807 words) - 19:07, 12 September 2024
  • Laboratory Braun – B. Braun Melsungen (Medical) Ltd Bristol-Myers SquibbBristol-Myers Squibb Pharmaceuticals Ltd Celltech – UCB Pharma Ltd Cephalon...
    8 KB (815 words) - 00:56, 9 July 2024
  • Medarex (category Drugs developed by Bristol Myers Squibb)
    Milpitas and Sunnyvale, California. In 2009, Medarex was purchased by Bristol Myers Squibb. Medarex developed monoclonal antibodies to CTLA-4 and PD-1, which...
    6 KB (615 words) - 07:01, 2 December 2023
  • Thumbnail for Milvexian
    prevention of blood clots in patients undergoing surgery. In 2018–2023, Bristol-Myers Squibb studied milvexian for the prevention of stroke. Perera V, Wang Z...
    4 KB (173 words) - 05:43, 28 June 2023
  • Mirati Therapeutics (category Bristol Myers Squibb)
    company that focuses on the development of cancer therapeutics. Bristol Myers Squibb acquired the company in January 2024. Mirati Therapeutics works largely...
    5 KB (354 words) - 01:43, 28 January 2024
  • Thumbnail for Mavacamten
    Mavacamten (category Drugs developed by Bristol Myers Squibb)
    myosin inhibitor. It was developed by MyoKardia, a subsidiary of Bristol Myers Squibb. In clinical studies, mavacamten has demonstrated significant efficacy...
    19 KB (1,217 words) - 01:27, 28 March 2024
  • Thumbnail for Captopril
    Captopril (category Drugs developed by Bristol Myers Squibb)
    drug company E.R. Squibb & Sons Pharmaceuticals (now Bristol-Myers Squibb): Miguel Ondetti, Bernard Rubin, and David Cushman. Squibb filed for U.S. patent...
    22 KB (2,241 words) - 16:59, 27 August 2024
  • Thumbnail for ZymoGenetics
    ZymoGenetics (category Bristol Myers Squibb)
    Eastlake Avenue East. It was closed in 2019 after its acquisition by Bristol Myers Squibb. The company was founded in 1981 by Professors Earl W. Davie and...
    13 KB (809 words) - 21:52, 13 September 2024
  • highlighted Glimcher’s activities on multiple corporate boards, including Bristol Myers Squibb, GlaxoSmithKline, and Analog Devices. After this investigation, Glimcher...
    25 KB (2,480 words) - 17:07, 24 August 2024
  • Thumbnail for Saxagliptin
    Saxagliptin (category Drugs developed by Bristol Myers Squibb)
    class. Early development was solely by Bristol-Myers Squibb; in 2007 AstraZeneca joined with Bristol-Myers Squibb to co-develop the final compound and collaborate...
    20 KB (1,961 words) - 20:50, 5 April 2024
  • biotechnology company Celgene for $9 billion. In November 2019, Bristol-Myers Squibb (BMS) announced that it has completed its acquisition of Celgene...
    9 KB (828 words) - 22:34, 22 January 2024
  • Mead Johnson & Company in 1905. The company was majority owned by Bristol-Myers Squibb after an acquisition in 1967, but was spun-off in 2009 as an independent...
    12 KB (1,083 words) - 11:51, 7 September 2024